Cargando…

Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor

The current study aimed to investigate the cardiotoxic effect of dexamethasone-high-dose in rats, the therapeutic effect of carvedilol and the role of α1-adrenergic receptor (α1AR). The experiment involved 6 groups: control, dexamethasone (10 mg/kg), carvedilol (10 mg/kg), phenylephrine (1 mg/kg), p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Rasha M. S. M., Ahmad, Enssaf Ahmad, Omran, Bothina H. F., Sakr, Amr T., Ibrahim, Islam A. A. E.-H., Mahmoud, Mona F., El-Naggar, Mostafa E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630193/ https://www.ncbi.nlm.nih.gov/pubmed/36085425 http://dx.doi.org/10.1007/s00210-022-02285-5

Ejemplares similares

Carvedilol Prevents Redox Inactivation of Cardiomyocyte Β(1)-Adrenergic Receptors
por: Park, Misun, et al.
Publicado: (2018)

Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits
por: Zubairi, Maysaa B., et al.
Publicado: (2014)

MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors
por: Han, Sang-oh, et al.
Publicado: (2012)

Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats
por: Morsy, Mohamed A., et al.
Publicado: (2014)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures
por: Vinik, Aaron I., et al.
Publicado: (2014)

Coriander Oil Reverses Dexamethasone-Induced Insulin Resistance in Rats
por: Mahmoud, Mona F., et al.
Publicado: (2022)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice
por: Nguyen, Linh V., et al.
Publicado: (2019)

Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results
por: Bloom, Heather L., et al.
Publicado: (2014)

Gα(i) is required for carvedilol-induced β(1) adrenergic receptor β-arrestin biased signaling
por: Wang, Jialu, et al.
Publicado: (2017)

Effect of beta‐adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial
por: Clark, Andrew L., et al.
Publicado: (2017)

Impact of R-Carvedilol on β2-Adrenergic Receptor-Mediated Spontaneous Calcium Release in Human Atrial Myocytes
por: Casabella-Ramón, Sergi, et al.
Publicado: (2022)

Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions
por: Chen, Sy-Jou, et al.
Publicado: (2019)

Carvedilol Ameliorates Intrahepatic Angiogenesis, Sinusoidal Remodeling and Portal Pressure in Cirrhotic Rats
por: Ling, Liping, et al.
Publicado: (2018)

Investigating Carvedilol’s Repurposing for the Treatment of Non-Small Cell Lung Cancer via Aldehyde Dehydrogenase Activity Modulation in the Presence of β-Adrenergic Agonists
por: Ikhmais, Balqis A., et al.
Publicado: (2023)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Withania somnifera ameliorates lead-induced augmentation of adrenergic response in rat portal vein
por: Hore, Subrata Kumar, et al.
Publicado: (2013)

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
por: Alanazi, Abeer M., et al.
Publicado: (2020)

Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study
por: Abdelmonem, Rehab, et al.
Publicado: (2021)

Carvedilol Exerts Neuroprotective Effect on Rat Model of Diabetic Neuropathy
por: Magadmi, Rania M., et al.
Publicado: (2021)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin
por: Abuosa, Ahmed Mohamed, et al.
Publicado: (2018)

Clinical value of detecting autoantibodies against β(1)-, β(2),- and α(1)-adrenergic receptors in carvedilol treatment of patients with heart failure
por: Hou, Dong-Yan, et al.
Publicado: (2020)

The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation
por: Farhoumand, Lina S., et al.
Publicado: (2022)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
por: Wani, Zeeshan Ahmad, et al.
Publicado: (2017)

Carvedilol, an Adrenergic Blocker, Suppresses Melanin Synthesis by Inhibiting the cAMP/CREB Signaling Pathway in Human Melanocytes and Ex Vivo Human Skin Culture
por: Choi, Myoung Eun, et al.
Publicado: (2020)

Carvedilol inhibits EGF-mediated JB6 P+ colony formation through a mechanism independent of adrenoceptors
por: Cleveland, Kristan H., et al.
Publicado: (2019)

Preclinical Evidences for an Antimanic Effect of Carvedilol
por: de Souza, Greicy Coelho, et al.
Publicado: (2015)

Carvedilol for the treatment of red scrotum syndrome
por: Merhi, Ribal, et al.
Publicado: (2017)

Hot Melt Coating of Amorphous Carvedilol
por: Bannow, Jacob, et al.
Publicado: (2020)

Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
por: Pani, Biswaranjan, et al.
Publicado: (2021)

The Effect of Dexamethasone, Adrenergic and Cholinergic Receptor Agonists on Phospholipid Metabolism in Human Osteoarthritic Synoviocytes
por: Sluzalska, Katarzyna D., et al.
Publicado: (2019)

Black pepper oil (Piper nigrum L.) mitigates dexamethasone induced pancreatic damage via modulation of oxidative and nitrosative stress
por: Mahmoud, Mona F., et al.
Publicado: (2022)

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
por: Eiamart, Wanna, et al.
Publicado: (2022)

Preparation and Characterization of a Novel Mucoadhesive Carvedilol Nanosponge: A Promising Platform for Buccal Anti-Hypertensive Delivery
por: Khafagy, El-Sayed, et al.
Publicado: (2022)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
por: Frishman, William H, et al.
Publicado: (2008)

Genistein Ameliorates Cyclophosphamide - Induced Hepatotoxicity by Modulation of Oxidative Stress and Inflammatory Mediators
por: Mansour, Dina F., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_14dcas459k2qij8q84870hmvmj